We are an innovative biotech start-up dedicated to advancing early-stage disease detection and vaccine development. Our research focuses on serious conditions such as pancreatic cancer, colorectal cancer (CRC), post-traumatic stress disorder (PTSD), and Alzheimer’s disease. Leveraging cutting-edge machine learning techniques and the latest advancements in gut microbiota science, we are driving transformative research and development.
In addition, we are pioneering vaccine research, with a tick-bite vaccine currently in our development pipeline.
Our team includes world-class experts in microbiota and vaccine R&D from Yale Medical School, as well as AI specialists from leading companies such as Walmart.
At our core, we are committed to improving health and well-being for all living creatures, striving to reduce pain and regret in the world through scientific innovation and compassionate care.
Leave a Reply
You must be logged in to post a comment.